These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
401 related items for PubMed ID: 3978626
21. Benzo(e)pyrene-induced alterations in the metabolic activation of benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene by hamster embryo cells. Baird WM, Salmon CP, Diamond L. Cancer Res; 1984 Apr; 44(4):1445-52. PubMed ID: 6322978 [Abstract] [Full Text] [Related]
22. Effect of butylated hydroxyanisole, alpha-angelica lactone, and beta-naphthoflavone on benzo(alpha)pyrene:DNA adduct formation in vivo in the forestomach, lung, and liver of mice. Ioannou YM, Wilson AG, Anderson MW. Cancer Res; 1982 Apr; 42(4):1199-204. PubMed ID: 7059996 [Abstract] [Full Text] [Related]
23. Aberrant activation of benzo(a)pyrene in cultured rat mammary cells in vitro and following direct application to rat mammary glands in vivo. Phillips DH, Hewer A, Grover PL. Cancer Res; 1985 Sep; 45(9):4167-74. PubMed ID: 3928151 [Abstract] [Full Text] [Related]
24. In vivo formation and persistence of DNA adducts in mouse and rat skin exposed to (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene and (+/-)-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene. Rojas M, Alexandrov K. Carcinogenesis; 1986 Sep; 7(9):1553-60. PubMed ID: 3091285 [Abstract] [Full Text] [Related]
25. Distribution of covalent DNA adducts in mouse epidermal subpopulations after topical application of benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene. Baer-Dubowska W, Morris RJ, Gill RD, DiGiovanni J. Cancer Res; 1990 May 15; 50(10):3048-54. PubMed ID: 2110503 [Abstract] [Full Text] [Related]
26. Benzo(e)pyrene-induced alterations in the binding of benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene to DNA in Sencar mouse epidermis. Smolarek TA, Baird WM, Fisher EP, DiGiovanni J. Cancer Res; 1987 Jul 15; 47(14):3701-6. PubMed ID: 3109730 [Abstract] [Full Text] [Related]
27. Metabolic activation of benzo(a)pyrene in SENCAR and BALB/c mouse embryo cell cultures. Baird WM, Sebti SM, Reinsvold LA. Environ Health Perspect; 1986 Sep 15; 68():45-52. PubMed ID: 3780631 [Abstract] [Full Text] [Related]
28. Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans. Wild CP, Hasegawa R, Barraud L, Chutimataewin S, Chapot B, Ito N, Montesano R. Cancer Epidemiol Biomarkers Prev; 1996 Mar 15; 5(3):179-89. PubMed ID: 8833618 [Abstract] [Full Text] [Related]
29. Inhibition in vivo of the formation of adducts between metabolites of benzo(a)pyrene and DNA by butylated hydroxyanisole. Anderson MW, Boroujerdi M, Wilson AG. Cancer Res; 1981 Nov 15; 41(11 Pt 1):4309-15. PubMed ID: 6272975 [Abstract] [Full Text] [Related]
30. Comparative in vitro and in vivo benzo[a]pyrene-DNA adduct formation and its relationship to CYP1A activity in two species of ictalurid catfish. Ploch SA, King LC, Kohan MJ, Di Giulio RT. Toxicol Appl Pharmacol; 1998 Mar 15; 149(1):90-8. PubMed ID: 9512731 [Abstract] [Full Text] [Related]
31. Quantification of (7S,8R)-dihydroxy-(9R,10S)-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene adducts in human serum albumin by laser-induced fluorescence: implications for the in vivo metabolism of benzo[a]pyrene. Ozbal CC, Skipper PL, Yu MC, London SJ, Dasari RR, Tannenbaum SR. Cancer Epidemiol Biomarkers Prev; 2000 Jul 15; 9(7):733-9. PubMed ID: 10919745 [Abstract] [Full Text] [Related]
32. Dose-response relationships for the binding of benzo(a)pyrene metabolites to DNA and protein in lung, liver, and forestomach of control and butylated hydroxyanisole-treated mice. Adriaenssens PI, White CM, Anderson MW. Cancer Res; 1983 Aug 15; 43(8):3712-9. PubMed ID: 6305492 [Abstract] [Full Text] [Related]
33. Molecular characterization of mutation and comparison of mutation profiles in the hprt gene of Chinese hamster ovary cells treated with benzo[a]pyrene trans-7,8-diol-anti-9,10-epoxide, 1-nitrobenzo[a]pyrene trans-7,8-diol-anti-9,10-epoxide, and 3-nitrobenzo[a]pyrene trans-7,8- diol-anti-9,10-epoxide. Zhan DJ, Heflich RH, Fu PP. Environ Mol Mutagen; 1996 Aug 15; 27(1):19-29. PubMed ID: 8625944 [Abstract] [Full Text] [Related]
34. Quantitation of benzo(a)pyrene metabolite: DNA adducts in selected hepatic and pulmonary cell types isolated from [3H]benzo(a)pyrene-treated rabbits. Horton JK, Rosenior JC, Bend JR, Anderson MW. Cancer Res; 1985 Aug 15; 45(8):3477-81. PubMed ID: 3926299 [Abstract] [Full Text] [Related]
35. Benzo(a)pyrene-DNA adduct formation and removal in mouse epidermis in vivo and in vitro: relationship of DNA binding to initiation of skin carcinogenesis. Nakayama J, Yuspa SH, Poirier MC. Cancer Res; 1984 Sep 15; 44(9):4087-95. PubMed ID: 6331664 [Abstract] [Full Text] [Related]
36. Comparative metabolism of benzo(a)pyrene and covalent binding to hepatic DNA in English sole, starry flounder, and rat. Varanasi U, Nishimoto M, Reichert WL, Le Eberhart BT. Cancer Res; 1986 Aug 15; 46(8):3817-24. PubMed ID: 3731058 [Abstract] [Full Text] [Related]
37. Rat and human explant metabolism, binding studies, and DNA adduct analysis of benzo(a)pyrene and its 6-nitro derivative. Garner RC, Stanton CA, Martin CN, Harris CC, Grafstrom RC. Cancer Res; 1985 Dec 15; 45(12 Pt 1):6225-31. PubMed ID: 4063973 [Abstract] [Full Text] [Related]
38. Metabolism of and DNA adduct formation by benzo[alpha]pyrene in human skin epithelial cells in vitro pretreated with cytochrome P450 modulators. Lehman TA, Kurian P, Milo GE. Cancer Biochem Biophys; 1989 Oct 15; 10(4):345-52. PubMed ID: 2515917 [Abstract] [Full Text] [Related]
39. Glutathione depletion suppresses conjugation of benzo[a]pyrene metabolites and (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene metabolites with glutathione but does not affect their binding to DNA in C3H/10T1/2 mouse fibroblasts. Hesse S, Krupski-Brennstuhl G, Cumpelik O, Mezger M, Wiebel FJ. Carcinogenesis; 1987 Aug 15; 8(8):1051-8. PubMed ID: 3608089 [Abstract] [Full Text] [Related]
40. Analysis of polycyclic aromatic hydrocarbon-DNA adducts by postlabelling with the weak beta-emitters 35S-phosphorothioate and 33P-phosphate, immobilized boronate chromatography and high-performance liquid chromatography. Baird WM, Lau HH, Schmerold I, Coffing SL, Brozich SL, Lee H, Harvey RG. IARC Sci Publ; 1993 Aug 15; (124):217-26. PubMed ID: 8225488 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]